Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Science
Standard protocols recommend 2-2.5 mg administered subcutaneously twice weekly for acute conditions, or 750 mcg twice weekly for maintenance therapy
bmiMD collaborates exclusively with licensed sterile compounding pharmacies throughout the United States
Phase 1: Activation (Weeks 14) Dose: Daily GHK-Cu activates collagen production while its copper component enables proper structural cross-linking BPC-157 builds the network of small blood vessels needed to feed active tissue TB-4 mobilizes and organizes repair cells Expected: Skin hydration improves, tone evens, and texture softens
The most-affected pathways include antioxidant defense, DNA repair, ubiquitin-proteasome activity, and TGF-beta signaling
This is a frontier
US$ 20.61
US$ 28.30
US$ 20.59
